HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Alphaxalone

HCID 104845
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
23930-19-0
Standard SMILES
CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C
InChIKey
DUHUCHOQIDJXAT-OLVMNOGESA-N
Molecular formula
C21H32O3
Average molar mass
332.5 g/mol
Monoisotopic mass
332.23514488

Overview

Alphaxolone is a corticosteroid hormone.

Names & identifiers

Preferred name
Alphaxalone
IUPAC
(3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one
English name
Alfaxalone
Molecular formula
C21H32O3
Molecular weight
332.48

Names & synonyms

AlfaxaloneAlphaxalone23930-19-0AlphaxoloneAlfaxalonaAlfaxalonumPhaxan3alpha-Hydroxy-5alpha-pregnane-11,20-dioneGR 2/234DTXSID9022576(3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-oneAlfadione
Show more names
gr2/234ALFAXALONE USP/EP/BP5A-pregnan-3A-ol-11,20-dione5α-Pregnan-3α-ol-11,20-dione3-hydroxypregnane-11,20-dione5α-PREGNAN-3α-OL-11, 20-DIONE
BD07M97B2AGR-2/234alfaxoloneDTXCID702576delta(16)-alfaxaloneAlfaxanAlfaxan Multidose(3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta(a)phenanthren-11-one

Database identifiers

CAS
23930-19-0

Properties

Computed structural properties

XLogP
3.2
Topological polar surface area
54.4 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
1
Heavy atoms
24
Formal charge
0
Complexity
569

Experimental & physicochemical properties

Drugs · 3 items

DEA Schedule IV Controlled Substance -> Depressants

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

Pharmaceuticals -> Listed in ZINC15

Animal Drugs · 2 items

FDA approved animal drugs -> Active ingredient

Pharmaceuticals -> UK Veterinary Medicines Directorate List

Collision Cross Section186.71 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
172 · 172-174°
alpha
26 · D26 +113.4° (c = 1.2 in chloroform).
Boiling point
409.59 °C · 409.59°C (rough estimate)
Density
1.0834 · 1.0834 (rough estimate)
refractive index
1.5192 · 1.5192 (estimate)
storage temp.
Store at RT
solubility

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 41 reports by companies from 1 notifications to the ECHA C&L Inventory.

Hazard information

Regulatory Information · 2 items

DEA schedule IV controlled substance

Alfaxalone: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Hazard Classes and CategoriesAcute Tox. 3 (100%)

Safety data

wgk
3
rtecs
TU4157800
ridadr
UN 2811 6.1/PG 3
Toxicity
LD50 i.v. in mice: 43 mg/kg (Al-Khawashki)
risk_code
22
Signal word
Danger
Symbol(GHS)
GHS06
hazard_code
Xn
safety_code
22-36
Hazard statements
H301
Precautionary statements
P301+P310

Chemistry & industry

Pharmacology

ATC Code · 2 items

N - Nervous system

QN - Nervous system

MeSH Pharmacological Classification · 2 items

Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site.

Endogenous compounds or drugs that affect neuronal excitability through modulation of specific ionotropic receptors (e.g., GABA-A RECEPTORS). Endogenous neurosteroids are steroid hormones de novo synthesized by neurons and glial cells from steroid metabolite precursors (e.g., PREGNENOLONE).

Applications · 2 items

DescriptionAlfaxalone (Alfaxan, Vetoquinol) is a neurologically active steroid compound that induces general anaesthesia. Alfaxalone exerts its action by binding to GABA receptors on the neuronal cell surface, affecting cell membrane chloride ion transport. It has negligible analgesic properties at therapeutic doses. Alfaxalone may be administered either intravenously or intramuscularly, and due to the possibility of apnoea after intravenous induction this route should be reserved for cases where intubation can be achieved[2].

UsesAnesthetic;nociception blocker

Upstream & downstream products

Upstream raw materials

Hydrogen11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dioneΔ16-Alfaxalone

Additional notes

Related reactions

7 records
New reaction record
HRID 918051 reaction equation
HRID 918051As reactant
HRID 1606469 reaction equation
HRID 1606469As reactant
HRID 1606470 reaction equation
HRID 1606470As reactant
HRID 1973717 reaction equation
HRID 1973717As reactant
HRID 1973719 reaction equation
HRID 1973719As reactant
HRID 1973738 reaction equation
HRID 1973738As reactant
HRID 1973740 reaction equation
HRID 1973740As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
PubChem CID
104845
DTXSID
DTXSID9022576
ChEMBL
CHEMBL190279
ChEBI
CHEBI:34531
UNII
BD07M97B2A
EC Number
636-625-6
Nikkaji
J3.157G
5 mg/mL, · chloroform: ≥5 mg/mL, clear, colorless
form
powder
pka
15.05 · 15.05±0.70(Predicted)
color
white
InChI
InChI=1/C21H32O3/c1-12(22)16-6-7-17-15-5-4-13-10-14(23)8-9-20(13,2)19(15)18(24)11-21(16,17)3/h13-17,19,23H,4-11H2,1-3H3/t13-,14+,15-,16+,17-,19+,20-,21+/s3
InChIKey
DUHUCHOQIDJXAT-YYJIQYHHNA-N
SMILES
[C@]12([H])C(=O)C[C@]3(C)[C@H](CC[C@@]3([H])[C@]1([H])CC[C@@]1([H])C[C@H](O)CC[C@]21C)C(=O)C |&1:0,5,7,10,12,16,19,23,r|
FDA UNII
7 M97B2A · BD07M97B2A
ATC code
1 AX05 · N01AX05
Symbol(GHS)
6 · GHS06
Signal word
Danger
Hazard statements
301 · H301
Precautionary statements
301 · P301+P310
Hazard Codes
Xn
Risk Statements
22 · 22
Safety Statements
22 · 22-36
RIDADR
2811 · UN 2811 6.1/PG 3
WGK Germany
3 · 3
RTECS
4157800 · TU4157800
Toxicity
50 i.v · LD50 i.v. in mice: 43 mg/kg (Al-Khawashki)

DefinitionChEBI: Alphaxolone is a corticosteroid hormone.